Biopharma spends an average of $90 billion per year on R&D, representing about 20% of total sales. Despite this significant financial investment by industry and splashy headlines in the media, how much, or little, is healthcare really digitizing?
During the recent JP Morgan Healthcare Conference, a panel of senior executives from Allergan, Google Cloud and New Enterprise Associates joined me to share their perspectives and insights on how biopharma and medtech companies are driving digital health.
Our panel of experts zeroed in on a few key trends:
Check out an article I wrote for Forbes that goes more in depth on these trends, including unique insights from our panelists.
Thank you to those of you who were able to join our event at JPM, and we hope to cross paths again soon.